Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00274521
Status:
COMPLETED
Last Update Posted:
2013-11-01
First Post:
2006-01-09
Brief Title:
Tiotropium Spiriva Rehabilitation Study
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
A Randomized Double-blind Placebo Controlled 25-week Trial to Compare the Effect of Tiotropium Inhalation Capsuled 18 Mcg Once Daily on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease COPD Participating in 8 Weeks of Pulmonary Rehabilitation
Status:
COMPLETED
Status Verified Date:
2013-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study was designed to determine whether tiotropium inhalation capsules compared to placebo enhances the improvement in exercise tolerance seen in patients with chronic obstructive pulmonary disease COPD who participate in pulmonary rehabilitation In addition assessments of the effect of tiotropium on dyspnea and quality of life following pulmonary rehabilitation were taken
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None